Tenascin-C Downregulates Wnt Inhibitor Dickkopf-1, Promoting Tumorigenesis in a Neuroendocrine Tumor Model
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
The extracellular matrix molecule tenascin-C (TNC) is a major component of the cancer-specific matrix, and high TNC expression is linked to poor prognosis in several cancers. To provide a comprehensive understanding of TNC's functions in cancer, we established an immune-competent transgenic mouse model of pancreatic β-cell carcinogenesis with varying levels of TNC expression and compared stochastic neuroendocrine tumor formation in abundance or absence of TNC. We show that TNC promotes tumor cell survival, the angiogenic switch, more and leaky vessels, carcinoma progression, and lung micrometastasis. TNC downregulates Dickkopf-1 (DKK1) promoter activity through the blocking of actin stress fiber formation, activates Wnt signaling, and induces Wnt target genes in tumor and endothelial cells. Our results implicate DKK1 downregulation as an important mechanism underlying TNC-enhanced tumor progression through the provision of a proangiogenic tumor microenvironment.
Inflammation in cancer: therapeutic opportunities from new insights.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q Mol Cancer. 2025; 24(1):51.
PMID: 39994787 PMC: 11849313. DOI: 10.1186/s12943-025-02243-8.
Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer.
Hartmann H, Loberg M, Xu G, Schwarzkopf A, Chen S, Phifer C Endocrinology. 2025; 166(3).
PMID: 39951495 PMC: 11843548. DOI: 10.1210/endocr/bqaf030.
Shaping Oncogenic Microenvironments: Contribution of Fibronectin.
Guerrero-Barbera G, Burday N, Costell M Front Cell Dev Biol. 2024; 12:1363004.
PMID: 38660622 PMC: 11039881. DOI: 10.3389/fcell.2024.1363004.
Extracellular matrix remodeling in the tumor immunity.
Du W, Xia X, Hu F, Yu J Front Immunol. 2024; 14:1340634.
PMID: 38332915 PMC: 10850336. DOI: 10.3389/fimmu.2023.1340634.
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.
Forsythe S, Pu T, Andrews S, Madigan J, Sadowski S Cancers (Basel). 2023; 15(15).
PMID: 37568572 PMC: 10416968. DOI: 10.3390/cancers15153756.